This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
DeepVerge has announced trial data showing its COVID-19 Microtox BT breath test can deliver accurate results in under 60 seconds, with a potential roll-out later this year if further tests support it. The company has already completed of the system that resembles a breathalyser in phase 1 and phase 2 studies with the SARS-CoV-2 virus in the safety of laboratories.
Saamaâs range of Smart applications will be integrated with the Oracle Health Sciences Clinical One platform to help users accelerate drug development.
Lymecycline is one of the most commonly used oral antibiotics in the treatment of acne. I previously reviewed the use of different antibiotics, including lymecycline for acne. In today’s post, I will focus solely on the use of lymecycline in the treatment of acne. Summary of the post: What is Lymecycline? The legal classification of lymecycline.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
The exact shape of healthcare’s post-COVID ‘new normal’ is still being framed, but it is clear that some trends are already taking shape – and one of the key ones is digital transformation in pharma. The pandemic has ushered in a number of major changes to healthcare systems, notably in the ways in which pharmaceutical companies communicate, visit and engage with physicians.
A leader from the trial solutions provider discusses how the COVID-19 pandemic has accelerated the already growing interest in remote patient monitoring.
Time for another life/blog/business update! I admit, I’m all over the place. It’s part of what makes me so fun, right? I’m constantly trying new things. Do I want to be a pro-blogger? I ran my little experiment with a more professional approach for blogging via The Money Mix Insiders program. While I learned a … March 2021 Reflections Read More ».
52
52
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Time for another life/blog/business update! I admit, I’m all over the place. It’s part of what makes me so fun, right? I’m constantly trying new things. Do I want to be a pro-blogger? I ran my little experiment with a more professional approach for blogging via The Money Mix Insiders program. While I learned a … March 2021 Reflections Read More ».
European regulators questioned the integrity of early batches of Pfizer/BioNTech’s mRNA vaccine, although the matter was resolved before approval, according to information leaked online following a cyberattack. As it conducted its analysis of the vaccine in December, the European Medicines Agency’s systems were targeted by unknown hackers. Following this, more than 40 megabytes of classified information from the agency’s review were published on the dark web and several journalists, including th
With the acquisition of the Spanish manufacturer STE Tecpharm, S. L., Romaco strengthens its position as a turnkey supplier of processing technologies. In particular, Tecpharm’s patented drum coaters will complement Romaco Innojet’s granulation and fluid bed technologies. On 18 March 2021, Romaco Holding GmbH announced the purchase of the Spanish manufacturer of processing technology STE Tecpharm, S.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
A host of companies are looking at cough apps to detect the presence of COVID-19. But one company called Hyfe wants to take the idea a step further and use them to detect future pandemics, reports Richard Staines. . The pandemic has seen a plethora of digital tools emerge to help manage patients remotely, with the ubiquitous use of smartphone technology allowing medics to monitor patients’ vital signs without risky face-to-face contact.
Today we have Dr. Nathalie van der Velde, Professor in Geriatrics at Amsterdam University Medical Centers (the Netherlands), telling about the development of STOPPFalls, part of the STOPP/START series, and the implications of this new tool. Take it away, Nathalie! Deprescribing is an essential component of falls prevention. Falls are the leading cause of injury and injury-related death among older adults and are among the biggest contributors to health care spending among community-dwelling olde
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
This content is password protected. To view it please enter your password below: Password: The post Protected: Using AI to make a big impact for emerging and mid-sized biopharma companies appeared first on.
[link]. Marketing and medical affairs are often perceived as being separate. What happens when drug companies market their own products? Join Darshan Kulkarni as he talks with guest Dr. Stephen Towers about the intersection between marketing and medical affairs. Darshan and Stephen also discuss how medical affairs can inform marketing efforts. The post DarshanTalks: Marketing & Medical Affairs </br>– March 9, 2021 appeared first on Pharma Marketing Network.
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Deutsches Zentrum fur Neurodegenerative Erkrankungen and Eisai Co., Ltd. today announced that both parties have entered into a research collaboration agreement aiming to create potential novel treatments for neurodegenerative disorders including Alzheimer’s disease (AD) which modulate immune competence in neurons and glia cells. DZNE is a world-leading interdisciplinary public research organization constituted with ten research sites in Germany that investigates methods for prevention, dia
The demise of the pharmaceutical sales representative has been greatly exaggerated over the years. But in the wake of the COVID-19 pandemic, there is an even greater need to re-examine the rep’s role. How can a field force evolve to deal with current challenges and be future-fit for the way we will be working in the post-pandemic world? The current restrictions on face-to-face meetings have exacerbated the trend of sales reps’ reduced access to healthcare customers.
As the vaccine goes into the arms of more people around the country, the US agency keeps on top of issues around the virus, offering resources and guidance.
Tamsulosin and finasteride are the two most common drugs licensed and used to manage benign prostatic hyperplasia (BPH). BPH is a condition characterised by an enlarged prostate, which may produce common symptoms such as increased urgency to urinate, poor urinary flow (difficult to start urination), increased urination at night (polyuria) and incomplete bladder emptying (individuals going back to the toilet few times because they feel they need to pee).
After over a half-century of lobbying, it seems that cannabis prohibition may finally come to an end at the federal level. For a lot of Americans, many of whom have seen their states legalize cannabis and marijuana products to varying degrees, this may seem like a natural course of events for the harmless but controversial plant. Except, cannabis isn’t entirely harmless.
A clinical trial has found that Novavax’ COVID-19 vaccine is 86% protective against the UK variant of SARS-CoV-2, only slightly lower than the 96% efficacy seen with the original strain of the virus. . The phase 3 trial – which takes Novavax’ NVX?CoV2373 shot a step closer to approval – also found that it was 100% effective in preventing severe COVID-19.
The two major pharmaceutical firms have agreed to jointly develop and commercialize treatment combinations of lenacapavir and islatravir in HIV patients.
PCR buffer is a vital component of the Polymerase Chain Reaction, also called molecular photocopying. The reaction has helped scientists worldwide study DNA by providing its ample amount from minimal samples. It is almost impossible to carry on a PCR reaction without a buffer. But what is the main function of a PCR Buffer? How does it help in creating DNA copies?
Roche has launched a new test that will help monitor emerging variants of the SARS-CoV-2 coronavirus. In a statement the company said the cobas SARS-CoV-2 Variant Set 1 Test is designed to detect key spike mutations in virus variants associated with increased human-to-human transmission. Detecting different variants of the virus can help assess the spread of circulating variants and monitor their potential impact on therapeutics, vaccines and public health interventions.
Cell and Gene Therapy Catapult (CGT Catapult) says that GSK will leverage its Stevenage facility to perform GMP cell processing and accelerate its cell and gene therapy pipeline for clinical trials.
I don’t see bromocriptine used very often in clinical practice, but as a pharmacist, I feel the need to know every medication I come across. Here’s a list of my top bromocriptine clinical pearls! I think one of the most important things to recognize is that bromocriptine is a dopamine agonist. If you remember this […]. The post Bromocriptine Clinical Pearls appeared first on Med Ed 101.
Gain Therapeutics has priced its initial public offering, raising more than $40 million for its computational drug discovery platform and pipeline of drugs for diseases associated with protein misfolding. . The shares began trading on the Nasdaq yesterday under the symbol ‘GANX’, closing at $11.20 and valuing the company at around $130 million. Bethesda, Maryland-headquartered Gain, which was originally formed in Switzerland, is focusing initial on lysosomal storage disorders (LSDs), a group of
The Orchestrated Customer Engagement Technology reportedly has been adopted by 140 life sciences companies (including top-10 pharma firms) in nearly 90.
52
52
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content